Global In Vitro Diagnostics Market Outlook, 2021

Global In Vitro Diagnostics Market Outlook, 2021

Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

RELEASE DATE
20-Sep-2021
REGION
North America
Research Code: K5C8-01-00-00-00
SKU: HC03451-NA-MT_25793
$4,950.00
In stock
SKU
HC03451-NA-MT_25793
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of the In Vitro Diagnostics (IVD) industry has unfolded through the COVID-19 pandemic, as it continued to serve the healthcare domain and successfully reach a revenue of $85.91 billion in 2020. Clinical chemistry and immunoassays dominate the revenue share; molecular diagnostics and point-of-care-testing continue to grow at the highest rates; and tissue diagnostics and hemostasis will experience moderate growth followed by rest of the technology segments. The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry. APAC, primarily driven by Japan, China, and India, along with the other growing economies will experience the highest growth rate, while Europe will continue to grow at a slower pace. Overall, this research service offers insightful analysis in the form of overall forecast, region, and technology segment wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry.

Author: Amol Dilip Jadhav

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the In Vitro Diagnostics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

In Vitro Diagnostics Market Scope of Analysis

In Vitro Diagnostics Market Based on Workflow

In Vitro Diagnostics Market Segmentation Based on Technologies

In Vitro Diagnostics Market Definition Technology Segments

In Vitro Diagnostics Market Segmentation Based on Region

Key Competitors for In Vitro Diagnostics Market

Key Growth Metrics for In Vitro Diagnostics Market

In Vitro Diagnostics Market Growth Outlook Summary

Decentralized Testing to Drive Growth—In Vitro Diagnostics Market

Growth Drivers for In Vitro Diagnostics Market

Growth Restraints for In Vitro Diagnostics Market

Forecast Assumptions—In Vitro Diagnostics Market

Revenue Forecast—In Vitro Diagnostics Market

Revenue Forecast by Workflow—In Vitro Diagnostics Market

Revenue Forecast by Technology—In Vitro Diagnostics Market

Revenue Forecast by Region—In Vitro Diagnostics Market

Revenue Forecast Analysis—In Vitro Diagnostics Market

Revenue Forecast Analysis by Workflow Segments—In Vitro Diagnostics Market

Revenue Forecast Analysis by Selective Technology Segments—In Vitro Diagnostics Market

Revenue Forecast Analysis by Selective Technology Segments—In Vitro Diagnostics Market (continued)

Revenue Forecast Analysis by Region—In Vitro Diagnostics Market

Competitive Environment—In Vitro Diagnostics Market

Revenue Share—In Vitro Diagnostics Market

Revenue Share Analysis—In Vitro Diagnostics Market

Competitor Matrix—In Vitro Diagnostics Market

Competitor Matrix—In Vitro Diagnostics Market (continued)

Competitor Segment Ranking—In Vitro Diagnostics Market

Recent Notable Activities—In Vitro Diagnostics Market

Recent Notable Activities—In Vitro Diagnostics Market (continued)

Key Growth Metrics for Clinical Chemistry and Immunoassay

Revenue Forecast—Clinical Chemistry and Immunoassay

Forecast Analysis—Clinical Chemistry and Immunoassay

Key Growth Metrics for Molecular Diagnostics

Revenue Forecast—Molecular Diagnostics

Forecast Analysis—Molecular Diagnostics

Key Growth Metrics for Tissue Diagnostics

Revenue Forecast—Tissue Diagnostics

Forecast Analysis—Tissue Diagnostics

Key Growth Metrics for Point-of-Care-Testing

Revenue Forecast—Point-of-Care-Testing

Forecast Analysis—Point-of-Care-Testing

Key Growth Metrics for In Vitro Diagnostics Market—North America

Revenue Forecast for In Vitro Diagnostics Market—North America

Forecast Analysis by Technology for In Vitro Diagnostics Market—North America

Key Growth Metrics for In Vitro Diagnostics Market—Europe

Revenue Forecast for In Vitro Diagnostics Market—Europe

Forecast Analysis by Technology for In Vitro Diagnostics Market—Europe

Key Growth Metrics for In Vitro Diagnostics Market—APAC

Revenue Forecast for In Vitro Diagnostics Market—APAC

Forecast Analysis by Technology for In Vitro Diagnostics Market—APAC

Growth Opportunity 1: POCT Instruments for Diagnosis of Respiratory Infections

Growth Opportunity 1: POCT Instruments for Diagnosis of Respiratory Infections (continued)

Growth Opportunity 2: Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics

Growth Opportunity 2: Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics (continued)

Growth Opportunity 3: Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology

Growth Opportunity 3: Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology (continued)

Growth Opportunity 4: Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time

Growth Opportunity 4: Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

Related Research
The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of the In Vitro Diagnostics (IVD) industry has unfolded through the COVID-19 pandemic, as it continued to serve the healthcare domain and successfully reach a revenue of $85.91 billion in 2020. Clinical chemistry and immunoassays dominate the revenue share; molecular diagnostics and point-of-care-testing continue to grow at the highest rates; and tissue diagnostics and hemostasis will experience moderate growth followed by rest of the technology segments. The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry. APAC, primarily driven by Japan, China, and India, along with the other growing economies will experience the highest growth rate, while Europe will continue to grow at a slower pace. Overall, this research service offers insightful analysis in the form of overall forecast, region, and technology segment wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry. Author: Amol Dilip Jadhav
More Information
No Index No
Podcast No
Author Amol Dilip Jadhav
Industries Healthcare
WIP Number K5C8-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9562-B1,9573-B1,99C6-B1,9627-B1